Quick Takeaways
- Laurence W. Lytton filed SCHEDULE 13G/A for NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, par value $0.001 (NMTC).
- Disclosed ownership: 2.6%.
- Date of event: 31 Mar 2025.
Laurence W. Lytton - 31 Mar 2025 SCHEDULE 13G/A Report for NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, par value $0.001 (NMTC)
- Filing Manager
- Laurence W. Lytton
- Reporting Manager
- LYTTON LAURENCE W
- Symbol
- NMTC
- Shares outstanding
- 49,818,769 shares
- Disclosed Ownership
- 1,295,288 shares
- Ownership
- 2.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 15:49:33 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Laurence W. Lytton disclosed 2.6% ownership in NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, par value $0.001 (NMTC) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 15:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 2.6% | 1,295,288 | 1,295,288 | 0 | /s/ Laurence W. Lytton | Reporting person |